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Introduction
Familial cold autoinflammatory syndrome, Muckle-Wells
syndrome (MWS), and chronic, infantile, neurological,
cutaneous and articular (CINCA) syndrome are domi-
nantly inherited autoinflammatory diseases associated to
gain-of-function NLRP3 mutations. All these diseases
are currently considered as different phenotypes of the
cryopyrin-associated periodic syndromes (CAPS). A vari-
able degree of somatic NLRP3 mosaicism has been
recently detected in ≈35% of patients with CINCA.
However, no data are currently available regarding the
relevance of this genetic mechanism in other CAPS
phenotypes.
Objective
To evaluate somatic NLRP3 mosaicism as the disease-
causing mechanism in patients with CAPS phenotypes
other than CINCA and NLRP3 mutation-negative by
conventional, Sanger-based genetic studies.
Materials and methods
NLRP3 analyses were performed by Sanger sequencing
and by targeted deep sequencing. Apoptosis-associated
Speck-like protein containing a CARD (ASC)-dependent
nuclear factor kappa-light chain enhancer of activated
B cells (NF-B) activation and transfection-induced
THP-1 cell death assays determined the functional conse-
quences of the detected variants.
Results
32 Spanish patients fulfilling clinical inclusion criteria
were enrolled. A variable degree (9.4-34.9%) of somatic
NLRP3 mosaicism was detected in 9.3% of enrolled
patients (3/32). Their clinical phenotypes were identical
to that seen in MWS. Three different missense variants
(p.D303A, p.L411F and p.F523L) were identified, being
two novels (p.D303A and p.L411F). Bioinformatic and
functional analyses confirmed that they were disease-
causing, gain-of-function NLRP3 mutations. Treatment
with anti-IL-1 drugs showed long-lasting and positive
clinical and biochemical responses.
Conclusion
We herein show novel evidence about the role of
somatic NLRP3 mosaicism in MWS pathogenesis, which
probably represents a shared genetic mechanism in
CAPS not restricted to CINCA syndrome. The data
here described allowed us to achieve the definitive diag-
noses of these patients, which have had serious clinical
implications such as gaining access to anti-IL-1 treat-
ments under legal indication and genetic counseling.
The detection of somatic gene mosaicism is difficult
when using conventional methods. Potential candidates
should benefit from the use of novel technologies such
as targeted deep sequencing.
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